Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Oct;48(10):955–960. doi: 10.1136/jcp.48.10.955

Diagnostic relevance of peripheral blood immunocytochemistry in hairy cell leukaemia.

I Cordone 1, L Annino 1, S Masi 1, E Pescarmona 1, S Rahimi 1, A Ferrari 1, E Giubilei 1, P Pignoloni 1, T Faraggiana 1, F Mandelli 1
PMCID: PMC502955  PMID: 8537498

Abstract

AIMS--(1) To assess the diagnostic relevance of peripheral blood immunocytochemistry in hairy cell leukaemia (HCL); (2) to compare the immunostaining of bone marrow biopsy specimens with bone marrow and peripheral blood cytospins; (3) to evaluate the sensitivity of the different markers used; (4) to identify the ultrastructural localisation of DBA.44 in HCL variant. METHODS--Immunoenzymatic staining procedures, immunoperoxidase and immunoalkaline phosphatase, were used with a panel of monoclonal antibodies directed to HCL associated antigens. Ultrastructural immunostaining was performed using colloidal gold conjugated antibodies. RESULTS--HCL showed strong cytoplasmic reactivity for CD22, CD25, CD103, DBA.44, kappa, or lambda light chains. Peripheral blood diagnostic hairy cells were found in all the cases with absolute counts ranging from 0.11 x 10(9)/l up to 6.4 x 10(9)/l and values increasing with the size of the spleen. A median of 36.5% of leukaemic cells was found in bone marrow aspirates and 70% in bone marrow trephine specimens. The monoclonal antibodies CD22 and DBA.44 showed the highest and the lowest percentage of positive hairy cells, respectively; this difference was statistically significant (p = 0.0025). Ultrastructural immunolabelling with DBA.44 showed a cytoplasmic membrane localisation of the antigen in one case of HCL variant. CONCLUSIONS--(1) Immunocytochemistry is a useful technique which enhances the accuracy of diagnosis in HCL; (2) peripheral blood immunocytochemistry is recommended because it highlights hairy cells in all cases; (3) CD22 appears to be the most sensitive of the markers tested; (4) ultrastructural analysis is a useful tool in selected cases of HCL variant.

Full text

PDF
955

Images in this article

957Image
on p.957
959Image
on p.959

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. C., Boyd A. W., Fisher D. C., Leslie D., Schlossman S. F., Nadler L. M. Hairy cell leukemia: a tumor of pre-plasma cells. Blood. 1985 Mar;65(3):620–629. [PubMed] [Google Scholar]
  2. Burke J. S. The value of the bone-marrow biopsy in the diagnosis of hairy cell leukemia. Am J Clin Pathol. 1978 Dec;70(6):876–884. doi: 10.1093/ajcp/70.6.876. [DOI] [PubMed] [Google Scholar]
  3. Chang K. L., Stroup R., Weiss L. M. Hairy cell leukemia. Current status. Am J Clin Pathol. 1992 May;97(5):719–738. doi: 10.1093/ajcp/97.5.719. [DOI] [PubMed] [Google Scholar]
  4. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  5. Cordone I., Matutes E., Catovsky D. Characterisation of normal peripheral blood cells in cycle identified by monoclonal antibody Ki-67. J Clin Pathol. 1992 Mar;45(3):201–205. doi: 10.1136/jcp.45.3.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Falini B., Pileri S. A., Flenghi L., Liberati M., Stein H., Gerli R., Minelli O., Martelli M. F., Lauria F., Poggi S. Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon-treated hairy cell leukaemia patients. Br J Haematol. 1990 Dec;76(4):460–468. doi: 10.1111/j.1365-2141.1990.tb07901.x. [DOI] [PubMed] [Google Scholar]
  7. Golomb H. M., Davis S., Wilson C., Vardiman J. Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia. Am J Hematol. 1982 Jun;12(4):397–401. doi: 10.1002/ajh.2830120411. [DOI] [PubMed] [Google Scholar]
  8. Hakimian D., Tallman M. S., Kiley C., Peterson L. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood. 1993 Sep 15;82(6):1798–1802. [PubMed] [Google Scholar]
  9. Hassan I. B., Hagberg H., Sundström C. Immunophenotype of hairy-cell leukemia. Eur J Haematol. 1990 Sep;45(3):172–176. doi: 10.1111/j.1600-0609.1990.tb00447.x. [DOI] [PubMed] [Google Scholar]
  10. Hounieu H., Chittal S. M., al Saati T., de Mascarel A., Sabattini E., Pileri S., Falini B., Ralfkiaer E., Le Tourneau A., Selves J. Hairy cell leukemia. Diagnosis of bone marrow involvement in paraffin-embedded sections with monoclonal antibody DBA.44. Am J Clin Pathol. 1992 Jul;98(1):26–33. doi: 10.1093/ajcp/98.1.26. [DOI] [PubMed] [Google Scholar]
  11. Kluin-Nelemans H. C., Krouwels M. M., Jansen J. H., Dijkstra K., van Tol M. J., den Ottolander G. J., Dreef E. J., Kluin P. M. Hairy cell leukemia preferentially expresses the IgG3-subclass. Blood. 1990 Feb 15;75(4):972–975. [PubMed] [Google Scholar]
  12. Kristensen J. S., Ellegaard J., Hokland P. A two-color flow cytometry assay for detection of hairy cells using monoclonal antibodies. Blood. 1987 Oct;70(4):1063–1068. [PubMed] [Google Scholar]
  13. Mulligan S. P., Travade P., Matutes E., Dearden C., Visser L., Poppema S., Catovsky D. B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. Blood. 1990 Sep 1;76(5):959–964. [PubMed] [Google Scholar]
  14. Piro L. D., Carrera C. J., Carson D. A., Beutler E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med. 1990 Apr 19;322(16):1117–1121. doi: 10.1056/NEJM199004193221605. [DOI] [PubMed] [Google Scholar]
  15. Robbins B. A., Ellison D. J., Spinosa J. C., Carey C. A., Lukes R. J., Poppema S., Saven A., Piro L. D. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood. 1993 Aug 15;82(4):1277–1287. [PubMed] [Google Scholar]
  16. Robinson D., Lackie P., Aber V., Catovsky D. Morphometric analysis of chronic B-cell leukemias--an aid to the classification of lymphoid cell types. Leuk Res. 1989;13(5):357–365. doi: 10.1016/0145-2126(89)90075-1. [DOI] [PubMed] [Google Scholar]
  17. Sainati L., Matutes E., Mulligan S., de Oliveira M. P., Rani S., Lampert I. A., Catovsky D. A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients. Blood. 1990 Jul 1;76(1):157–162. [PubMed] [Google Scholar]
  18. Saven A., Piro L. D. Treatment of hairy cell leukemia. Blood. 1992 Mar 1;79(5):1111–1120. [PubMed] [Google Scholar]
  19. Saven A., Piro L. Newer purine analogues for the treatment of hairy-cell leukemia. N Engl J Med. 1994 Mar 10;330(10):691–697. doi: 10.1056/NEJM199403103301007. [DOI] [PubMed] [Google Scholar]
  20. Visser L., Shaw A., Slupsky J., Vos H., Poppema S. Monoclonal antibodies reactive with hairy cell leukemia. Blood. 1989 Jul;74(1):320–325. [PubMed] [Google Scholar]
  21. Visser L., Shaw A., Slupsky J., Vos H., Poppema S. Monoclonal antibodies reactive with hairy cell leukemia. Blood. 1989 Jul;74(1):320–325. [PubMed] [Google Scholar]
  22. al Saati T., Caspar S., Brousset P., Chittal S., Caverivière P., Hounieu H., Dastugue N., Idoipe J. B., Icart J., Mazerolles C. Production of anti-B monoclonal antibodies (DBB.42, DBA.44, DNA.7, and DND.53) reactive on paraffin-embedded tissues with a new B-lymphoma cell line grafted into athymic nude mice. Blood. 1989 Nov 15;74(7):2476–2485. [PubMed] [Google Scholar]
  23. de Totero D., Tazzari P. L., Lauria F., Raspadori D., di Celle P. F., Carbone A., Gobbi M., Foa R. Phenotypic analysis of hairy cell leukemia: "variant" cases express the interleukin-2 receptor beta chain, but not the alpha chain (CD25). Blood. 1993 Jul 15;82(2):528–535. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES